Position in OGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$811,763
+$481,080 QoQ
Shares Held
59,953
+8.6% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#161
of 625 holders
Holding Since
Dec 2022
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CITIZENS FINANCIAL GROUP INC/RI holds $256,985,813 across 10 Drug Manufacturers - General names. OGN ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
76,092 | $91,267,035 | |
| 2 | JNJ |
Johnson & Johnson
|
210,648 | $53,498,271 | |
| 3 | ABBV |
AbbVie Inc.
|
200,168 | $50,370,275 | |
| 4 | MRK |
Merck & Co., Inc.
|
261,913 | $33,655,820 | |
| 5 | AMGN |
Amgen Inc
|
33,247 | $12,039,402 | |
| 6 | PFE |
Pfizer Inc
|
309,137 | $7,444,018 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
77,229 | $4,449,934 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
21,689 | $2,740,187 |
All Filings in OGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $811,763 | 59,953 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $330,683 | 55,206 | Shares | Defined | 2026-05-01 | |
| 2023-03-31 | $216,877 | 9,221 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $250,643 | 8,974 | Shares | Defined | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||